Anti-neoplastic activity of two flavone isomers derived from Gnaphalium elegans and achyrocline bogotensis

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Thomas, Christan M ^a   Wood III, Robert C ^a   Wyatt, Jarrett E ^a   Pendleton, Morgan H ^a   Torrenegra, Ruben D ^b   Rodriguez, Oscar E ^b   Harirforoosh, Sam ^a   Ballester, Maria ^c   Lightner, Janet ^d   Krishnan, Koyamangalath ^d   Ramsauer, Victoria P ^a,d  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b UNIVERSIDAD DE CIENCIAS APLICADAS Y AMBIENTALES   (Colombia)

^c NOVA SOUTHEASTERN UNIVERSITY   (United States)

^d East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DIHYDROXY 6,7,8 TRIMETHOXYFLAVONE; 5,7 DIHYDROXY 3,6,8 TRIMETHOXYFLAVONE; FLAVONE DERIVATIVE; UNCLASSIFIED DRUG;

ACHYROCLINE; ACHYROCLINE BOGOTENSIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASTERACEAE; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENESIS; CELL ASSAY; CELL DEATH; CELL SPECIFICITY; CELL STRAIN CACO 2; CELL STRAIN HCT116; CELL STRAIN LNCAP; CELL STRAIN MCF 7; CELL STRAIN MIA PACA; CELL STRAIN PANC 28; CELL STRAIN PC3; CELL STRAIN SK BR 3; CELL VIABILITY; COLON CANCER; CONCENTRATION RESPONSE; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; GNAPHALIUM; GNAPHALIUM ELEGANS; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NICK END LABELING; PANCREAS CANCER; PROSTATE CANCER; TUMOR DIFFERENTIATION;

ACHYROCLINE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DEATH; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FIBROBLASTS; FLAVONES; GNAPHALIUM; HUMANS; IN SITU NICK-END LABELING; ISOMERISM; MALE; PHYTOTHERAPY;

ACHYROCLINE; AGOUTI PACA; ASTERACEAE; GNAPHALIUM; PSEUDOGNAPHALIUM ELEGANS;

EID: 84863111694     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039806     Document Type: Article

References (43)

1. Torrenegra RD, Escarria S, Tenorio E, Achenbach H, (1982) Estudio fitoquimico del Achirocline bogotensis. Rev Latinoam Quim 13: 75-76.
2. Torrenegra R, Pedrozo P, Rojas C, Carrizosa S, (1987) Plantas Colombianas del género Gnaphalium (IV) G. rufescens y G. antennarioides. Revista Latinoamericana de Química 18: 116-118.
3. Torrenegra RD, Escarria S, Raffelsberger B, Achenbach H, (1980) 5,7-Dihydroxy-3,6,8-trimethoxyflavone from the flowers of Gnaphalium elegans. Phytochemistry 19: 2795-2796.
4. Garcia-Barriga H, (1975) Flora Medicinal de Colombia. Bogota: Imprenta Nacional III.
5. Perez-Vizcaino F, Duarte J, Jimenez R, Santos-Buelga C, Osuna A, (2009) Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep 61: 67-75.
6. Wang S, Thomas CJ, Dusting GJ, Woodman OL, May CN, (2009) 3′,4′-Dihydroxyflavonol improves post-ischaemic coronary endothelial function following 7days reperfusion in sheep. Eur J Pharmacol 624: 31-37.
7. Garcia-Lafuente A, Guillamon E, Villares A, Rostagno MA, Martinez JA, (2009) Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res 58: 537-552.
8. Javed H, Khan MM, Ahmad A, Vaibhav K, Ahmad ME, et al. (2012) Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type. Neuroscience.
9. Cushnie TP, Lamb AJ, (2005) Antimicrobial activity of flavonoids. Int J Antimicrob Agents 26: 343-356.
10. Fiamegos YC, Kastritis PL, Exarchou V, Han H, Bonvin AM, et al. (2011) Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria. PLoS One 6: e18127.
11. Le Marchand L, (2002) Cancer preventive effects of flavonoids-a review. Biomed Pharmacother 56: 296-301.
12. Dandawate PR, Vyas A, Ahmad A, Banerjee S, Deshpande J, et al. (2012) Inclusion Complex of Novel Curcumin Analogue CDF and beta-Cyclodextrin (1:2) and Its Enhanced In Vivo Anticancer Activity Against Pancreatic Cancer. Pharm Res.
13. Lopez-Lazaro M, (2002) Flavonoids as anticancer agents: structure-activity relationship study. Curr Med Chem Anticancer Agents 2: 691-714.
14. Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, et al. (2005) The antitumor activities of flavonoids. In Vivo 19: 895-909.
15. Kale A, Gawande S, Kotwal S, (2008) Cancer phytotherapeutics: role for flavonoids at the cellular level. Phytother Res 22: 567-577.
16. Wang HK, (2000) The therapeutic potential of flavonoids. Expert Opin Investig Drugs 9: 2103-2119.
17. Tseng TH, Lee YJ, (2006) Evaluation of natural and synthetic compounds from East Asiatic folk medicinal plants on the mediation of cancer. Anticancer Agents Med Chem 6: 347-365.
18. Liu HL, Jiang WB, Xie MX, (2010) Flavonoids: recent advances as anticancer drugs. Recent Pat Anticancer Drug Discov 5: 152-164.
19. Sclabas GM, Fujioka S, Schmidt C, Evans DB, Chiao PJ, (2003) NF-kappaB in pancreatic cancer. Int J Gastrointest Cancer 33: 15-26.
20. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, et al. (1980) The LNCaP cell line-a new model for studies on human prostatic carcinoma. Prog Clin Biol Res 37: 115-132.
21. Lim DJ, Liu XL, Sutkowski DM, Braun EJ, Lee C, et al. (1993) Growth of an androgen-sensitive human prostate cancer cell line, LNCaP, in nude mice. Prostate 22: 109-118.
22. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW, (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23.
23. Xiong HP, Wu ZJ, Chen FT, Chen WS, (2009) 5,7-Dihydr-oxy-3,6,8-trimethoxy-flavone. Acta Crystallogr Sect E Struct Rep Online 65: o3276-3277.
24. Tomás-Lorente F, Iniesta-Sanmartín E, Tomás-Barberán FA, Trowitzsch-Kienast W, Wray V, (1989) Antifungal phloroglucinol derivatives and lipophilic flavonoids from Helichrysum decumbens. Phytochemistry 28: 1613-1615.
25. Hansel R, Cubukcu B, (1972) 3,5-Dihydroxy-6,7,8-trimethoxyflavon aus Helichrysum graveolens. Phytochemistry 11: 2632.
26. Van Puyvelde L, De Kimpe N, Costa J, Munyjabo V, Nyirankuliza S, et al. (1989) Isolation of flavonoids and a chalcone from Helichrysum odoratissimum and synthesis of helichrysetin. J Nat Prod 52: 629-633.
27. Suzgec S, Mericli AH, Houghton PJ, Cubukcu B, (2005) Flavonoids of Helichrysum compactum and their antioxidant and antibacterial activity. Fitoterapia 76: 269-272.
28. Lee SH, Ryu JK, Lee KY, Woo SM, Park JK, et al. (2008) Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer. Cancer Lett 259: 39-49.
29. Shin SY, Hyun J, Yu JR, Lim Y, Lee YH, (2011) 5-Methoxyflavanone induces cell cycle arrest at the G2/M phase, apoptosis and autophagy in HCT116 human colon cancer cells. Toxicol Appl Pharmacol 254: 288-298.
30. Erhart LM, Lankat-Buttgereit B, Schmidt H, Wenzel U, Daniel H, et al. (2005) Flavone initiates a hierarchical activation of the caspase-cascade in colon cancer cells. Apoptosis 10: 611-617.
31. Torres F, Quintana J, Estevez F, (2010) 5,7,3′-trihydroxy-3,4′-dimethoxyflavone-induced cell death in human leukemia cells is dependent on caspases and activates the MAPK pathway. Mol Carcinog 49: 464-475.
32. Middleton E Jr, Kandaswami C, Theoharides TC, (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52: 673-751.
33. Middleton ET, Morice AH, (2000) Breath carbon monoxide as an indication of smoking habit. Chest 117: 758-763.
34. Neumeister V, Agarwal S, Bordeaux J, Camp RL, Rimm DL, (2010) In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis. Am J Pathol 176: 2131-2138.
35. Lin L, Liu Y, Li H, Li PK, Fuchs J, et al. (2011) Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030. Br J Cancer 105: 212-220.
36. Visus C, Wang Y, Lozano-Leon A, Ferris RL, Silver S, et al. (2011) Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8 T cells. Clin Cancer Res 17: 6174-6184.
37. Karna P, Gundala SR, Gupta MV, Shamsi SA, Pace RD, et al. (2011) Polyphenol-rich sweet potato greens extract inhibits proliferation and induces apoptosis in prostate cancer cells in vitro and in vivo. Carcinogenesis 32: 1872-1880.
38. Schumacher M, Hautzinger A, Rossmann A, Holzhauser S, Popovic D, et al. (2011) Potential role of P-gp for flavone-induced diminished apoptosis and increased adenoma size in the small intestine of APC(min/+) mice. Cancer Invest 29: 396-404.
39. Choi EJ, Kim GH, (2009) 5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells. Oncol Rep 22: 1533-1537.
40. Sipos B, Moser S, Kalthoff H, Torok V, Lohr M, et al. (2003) A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch 442: 444-452.
41. Menter DG, Ramsauer VP, Harirforoosh S, Chakraborty K, Yang P, et al. (2011) Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites. PLoS One 6: e28813.
42. Moghaddam G, Ebrahimi SA, Rahbar-Roshandel N, Foroumadi A, (2011) Antiproliferative Activity of Flavonoids: Influence of the Sequential Methoxylation State of the Flavonoid Structure. Phytother Res.
43. Singh M, Bhatnagar P, Srivastava AK, Kumar P, Shukla Y, et al. (2011) Enhancement of cancer chemosensitization potential of cisplatin by tea polyphenols poly(lactide-co-glycolide) nanoparticles. J Biomed Nanotechnol 7: 202.